Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tomoaki Terakawa

Showing results (1-10 of 110) with videos related to

Pageof 11
Sort By:
Urologic Oncology|April 12, 2011
Expression level of vascular endothelial growth factor receptor-2 in radical nephrectomy specimens as a prognostic predictor in patients with metastatic renal cell carcinoma treated with sunitinibTomoaki Terakawa, Hideaki Miyake, Yuji Kusuda, et al.
Cancer Science|January 11, 2011
Inhibition of tumor growth and sensitization to chemotherapy by RNA interference targeting interleukin-6 in the androgen-independent human prostate cancer PC3 modelIori Sakai, Hideaki Miyake, Tomoaki Terakawa, et al.
Oncology Letters|August 1, 2012
Growth inhibition and enhanced chemosensitivity induced by down-regulation of Aurora-A in human renal cell carcinoma Caki-2 cells using short hairpin RNATomoaki Terakawa, Hideaki Miyake, Masafumi Kumano, et al.
Hinyokika Kiyo. Acta Urologica Japonica|April 28, 2005
[A case of retroperitoneal liposarcoma arising from the renal capsule]Tomoaki Terakawa, Isao Taguchi, Osamu Imanishi, et al.
Current Urology|June 12, 2014
Significance of uracil/tegafur for preventing intravesical recurrence of non-muscle invasive urothelial carcinoma of the bladderKen-Ichi Harada, Hideaki Miyake, Tomoaki Terakawa, et al.
Clinical Genitourinary Cancer|July 18, 2016
Comparative Assessment of Clinical Outcomes Between Abiraterone Acetate and Enzalutamide in Patients With Docetaxel-Naive Metastatic Castration-Resistant Prostate Cancer: Experience in Real-World Clinical Practice in JapanHideaki Miyake, Takuto Hara, Tomoaki Terakawa, et al.
Urological Research|October 15, 2003
Solitary fibrous tumor in the pelvic spaceTomomoto Ishikawa, Gaku Kawabata, Tomoaki Terakawa, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|September 1, 2007
Clinical outcome of surgical management for patients with renal cell carcinoma involving the inferior vena cavaTomoaki Terakawa, Hideaki Miyake, Atsushi Takenaka, et al.
Urology|September 20, 2011
Expression profile of E-cadherin and N-cadherin in urothelial carcinoma of the upper urinary tract is associated with disease recurrence in patients undergoing nephroureterectomyMototsugu Muramaki, Hideaki Miyake, Tomoaki Terakawa, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|August 25, 2010
Salvage chemotherapy with methotrexate, etoposide and actinomycin D in men with metastatic nonseminomatous germ cell tumors with a choriocarcinoma component: a preliminary reportTomoaki Terakawa, Hideaki Miyake, Mototsugu Muramaki, et al.
Pageof 11

Showing results (1-10 of 110) with videos related to

Sort By:
Pageof 11
Urologic Oncology|April 12, 2011
Expression level of vascular endothelial growth factor receptor-2 in radical nephrectomy specimens as a prognostic predictor in patients with metastatic renal cell carcinoma treated with sunitinibTomoaki Terakawa, Hideaki Miyake, Yuji Kusuda, et al.
Cancer Science|January 11, 2011
Inhibition of tumor growth and sensitization to chemotherapy by RNA interference targeting interleukin-6 in the androgen-independent human prostate cancer PC3 modelIori Sakai, Hideaki Miyake, Tomoaki Terakawa, et al.
Oncology Letters|August 1, 2012
Growth inhibition and enhanced chemosensitivity induced by down-regulation of Aurora-A in human renal cell carcinoma Caki-2 cells using short hairpin RNATomoaki Terakawa, Hideaki Miyake, Masafumi Kumano, et al.
Hinyokika Kiyo. Acta Urologica Japonica|April 28, 2005
[A case of retroperitoneal liposarcoma arising from the renal capsule]Tomoaki Terakawa, Isao Taguchi, Osamu Imanishi, et al.
Current Urology|June 12, 2014
Significance of uracil/tegafur for preventing intravesical recurrence of non-muscle invasive urothelial carcinoma of the bladderKen-Ichi Harada, Hideaki Miyake, Tomoaki Terakawa, et al.
Clinical Genitourinary Cancer|July 18, 2016
Comparative Assessment of Clinical Outcomes Between Abiraterone Acetate and Enzalutamide in Patients With Docetaxel-Naive Metastatic Castration-Resistant Prostate Cancer: Experience in Real-World Clinical Practice in JapanHideaki Miyake, Takuto Hara, Tomoaki Terakawa, et al.
Urological Research|October 15, 2003
Solitary fibrous tumor in the pelvic spaceTomomoto Ishikawa, Gaku Kawabata, Tomoaki Terakawa, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|September 1, 2007
Clinical outcome of surgical management for patients with renal cell carcinoma involving the inferior vena cavaTomoaki Terakawa, Hideaki Miyake, Atsushi Takenaka, et al.
Urology|September 20, 2011
Expression profile of E-cadherin and N-cadherin in urothelial carcinoma of the upper urinary tract is associated with disease recurrence in patients undergoing nephroureterectomyMototsugu Muramaki, Hideaki Miyake, Tomoaki Terakawa, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|August 25, 2010
Salvage chemotherapy with methotrexate, etoposide and actinomycin D in men with metastatic nonseminomatous germ cell tumors with a choriocarcinoma component: a preliminary reportTomoaki Terakawa, Hideaki Miyake, Mototsugu Muramaki, et al.
Pageof 11